Supernus Pharmaceuticals buy marge
Start price
21.06.15
/
50%
€14.50
Target price
22.07.15
€18.00
Performance (%)
24.25%
End price
22.07.15
€18.02
Summary
This prediction ended on 22.07.15 with a price of €18.02. The prediction had a final performance of 24.25%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Supernus Pharmaceuticals | 4.286% | 4.286% | 19.672% | 19.672% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% | 64.694% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% | 109.729% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% | 55.832% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% | 67.674% |
Comments by marge for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Supernus
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Vom Mitglied beendet)